Christine Knuehl

Christine Knuehl

Company: Merck KGaA Darmstadt Germany

Job title: Translational and Biomarker Research Leader, TIP Oncology & Immuno-Oncology


M1231, a Novel Bispecific Anti-MUC1xEGFR ADC 12:00 pm

M1231 is a bispecific ADC for the treatment of solid tumors coexpressing MUC1 and EGFR • Discuss the advantages of a bispecific ADC approach • Review mechanism of action and preclinical profile of M1231Read more

day: day 1 track 2 am

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.